These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 31399185
1. Glycogen Synthase Kinase-3β Inhibitor Attenuates Renal Damage Through Regulating Antioxidant and Anti-inflammation in Rat Kidney Transplant With Cold Ischemia Reperfusion. Hu B, Tang J, Zhang Y, Ma Z, Shan Y, Liu J, Shen X, Qian P. Transplant Proc; 2019; 51(6):2066-2070. PubMed ID: 31399185 [Abstract] [Full Text] [Related]
2. GSK-3β Inhibitor Induces Expression of the TLR4/MyD88/NF-κB Signaling Pathway to Protect Against Renal Ischemia-Reperfusion Injury During Rat Kidney Transplantation. Su S, Zhang P, Zhang Q, Yin Z. Inflammation; 2019 Dec; 42(6):2105-2118. PubMed ID: 31440938 [Abstract] [Full Text] [Related]
3. Activation of Nrf2/HO-1 Pathway by Glycogen Synthase Kinase-3β Inhibition Attenuates Renal Ischemia/Reperfusion Injury in Diabetic Rats. Shen X, Hu B, Xu G, Chen F, Ma R, Zhang N, Liu J, Ma X, Zhu J, Wu Y, Shen R. Kidney Blood Press Res; 2017 Dec; 42(2):369-378. PubMed ID: 28624830 [Abstract] [Full Text] [Related]
4. GSK-3β inhibitor TDZD-8 prevents reduction of aquaporin-1 expression via activating autophagy under renal ischemia reperfusion injury. Liu Q, Kong Y, Guo X, Liang B, Xie H, Hu S, Han M, Zhao X, Feng P, Lyu Q, Dong W, Liang X, Wang W, Li C. FASEB J; 2021 Aug; 35(8):e21809. PubMed ID: 34314052 [Abstract] [Full Text] [Related]
5. GSK-3beta Inhibitor Induces Expression of Nrf2/TrxR2 Signaling Pathway to Protect against Renal Ischemia/Reperfusion Injury in Diabetic Rats. Hu B, Wu Y, Liu J, Shen X, Tong F, Xu G, Shen R. Kidney Blood Press Res; 2016 Aug; 41(6):937-946. PubMed ID: 27924803 [Abstract] [Full Text] [Related]
6. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus. Collino M, Thiemermann C, Mastrocola R, Gallicchio M, Benetti E, Miglio G, Castiglia S, Danni O, Murch O, Dianzani C, Aragno M, Fantozzi R. Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734 [Abstract] [Full Text] [Related]
7. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Collino M, Aragno M, Castiglia S, Tomasinelli C, Thiemermann C, Boccuzzi G, Fantozzi R. Diabetes; 2009 Jan; 58(1):235-42. PubMed ID: 18840784 [Abstract] [Full Text] [Related]
8. Inhibition of glycogen synthase kinase-3β prevents activation of focal adhesion kinase after ischemia/reperfusion of the rat lung. Waldow T, Witt W, Matschke K. Clin Hemorheol Microcirc; 2010 Jan; 46(2-3):169-81. PubMed ID: 21135492 [Abstract] [Full Text] [Related]
9. GSK-3β inhibition confers cardioprotection associated with the restoration of mitochondrial function and suppression of endoplasmic reticulum stress in sevoflurane preconditioned rats following ischemia/reperfusion injury. Wang Y, Ge C, Chen J, Tang K, Liu J. Perfusion; 2018 Nov; 33(8):679-686. PubMed ID: 29987974 [Abstract] [Full Text] [Related]
10. [Experimental study on the mechanism of glycogen synthase kinase-3β inhibitor on acute kidney injury of acute necrotizing pancreatitis in rats]. Zhao K, Yang X, Chen C, Zhao L, Mei F, Hong Y, Wang W. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jun; 31(6):719-724. PubMed ID: 31315730 [Abstract] [Full Text] [Related]
11. Inhibition of Glycogen Synthase Kinase 3β Alleviates Chronic Renal Allograft Dysfunction in Rats. Deng J, Wang X, Zhou Q, Xia Y, Xiong C, Shao X, Zou H. Transplantation; 2021 Apr 01; 105(4):757-767. PubMed ID: 32890133 [Abstract] [Full Text] [Related]
12. Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β. Liu H, Ou S, Xiao X, Zhu Y, Zhou S. Am J Med Sci; 2015 Sep 01; 350(3):204-11. PubMed ID: 26226547 [Abstract] [Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3β attenuates organ injury and dysfunction associated with liver ischemia-reperfusion and thermal injury in the rat. Rocha J, Figueira ME, Barateiro A, Fernandes A, Brites D, Pinto R, Freitas M, Fernandes E, Mota-Filipe H, Sepodes B. Shock; 2015 Apr 01; 43(4):369-78. PubMed ID: 25394244 [Abstract] [Full Text] [Related]
14. Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut. Cuzzocrea S, Mazzon E, Esposito E, Muià C, Abdelrahman M, Di Paola R, Crisafulli C, Bramanti P, Thiemermann C. Intensive Care Med; 2007 May 01; 33(5):880-893. PubMed ID: 17384932 [Abstract] [Full Text] [Related]
15. Glycogen synthase kinase-3β inhibitor ameliorates imbalance of connexin 43 in an acute kidney injury model. Wang Y, Tong K. Toxicol Rep; 2015 May 01; 2():1391-1395. PubMed ID: 28962480 [Abstract] [Full Text] [Related]
16. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice. Singh SP, Tao S, Fields TA, Webb S, Harris RC, Rao R. Dis Model Mech; 2015 Aug 01; 8(8):931-40. PubMed ID: 26092126 [Abstract] [Full Text] [Related]
17. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis. Gao HK, Yin Z, Zhou N, Feng XY, Gao F, Wang HC. J Cardiovasc Pharmacol; 2008 Sep 01; 52(3):286-92. PubMed ID: 18806610 [Abstract] [Full Text] [Related]
18. Insulin reduces the multiple organ injury and dysfunction caused by coadministration of lipopolysaccharide and peptidoglycan independently of blood glucose: role of glycogen synthase kinase-3beta inhibition. Dugo L, Collin M, Allen DA, Murch O, Foster SJ, Yaqoob MM, Thiemermann C. Crit Care Med; 2006 May 01; 34(5):1489-96. PubMed ID: 16557150 [Abstract] [Full Text] [Related]
19. GSK-3β inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice. Huang S, Wang H, Turlova E, Abussaud A, Ji X, Britto LR, Miller SP, Martinez A, Sun HS, Feng ZP. CNS Neurosci Ther; 2017 May 01; 23(5):405-415. PubMed ID: 28256059 [Abstract] [Full Text] [Related]